BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hepatitis
,
Neuron
,
Nosology
,
Acetaminophen
,
rs2476601
,
MDM2
,
T cell differentiation
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
K-247
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Ligand symmetry significantly affects spin crossover behaviour in isomeric [Fe(pybox)2]2+ complexes.
Adding Insult to Injury: Mechanistic Basis for How AmpC Mutations Allow Pseudomonas aeruginosa To Ac…
Preoperative direct oral anticoagulants treatment and all-cause mortality in elderly patients with h…
Clinical trial of K-247].
Effect of p-aminobenzoic acid N-xyloside sodium salt (K-247) on metabolism and functions of normal l…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K…
Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic An…
INR Control and Atrial Fibrillation in Primary Care in Spain (PAULA)
Patient Convenience Study
ZS Ph2/3 Dose-response Study in Japan
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ